| Year |
Citation |
Score |
| 2016 |
Otręebska-Machaj E, Chevalier J, Handzlik J, Szymańska E, Schabikowski J, Boyer G, Bolla JM, Kieć-Kononowicz K, Pagès JM, Alibert S. Efflux Pump Blockers in Gram-Negative Bacteria: The New Generation of Hydantoin Based-Modulators to Improve Antibiotic Activity. Frontiers in Microbiology. 7: 622. PMID 27199950 DOI: 10.3389/Fmicb.2016.00622 |
0.522 |
|
| 2015 |
Cinquin B, Maigre L, Pinet E, Chevalier J, Stavenger RA, Mills S, Réfrégiers M, Pagès JM. Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level. Scientific Reports. 5: 17968. PMID 26656111 DOI: 10.1038/Srep17968 |
0.463 |
|
| 2014 |
Fadli M, Chevalier J, Hassani L, Mezrioui NE, Pagès JM. Natural extracts stimulate membrane-associated mechanisms of resistance in Gram-negative bacteria. Letters in Applied Microbiology. 58: 472-7. PMID 24447247 DOI: 10.1111/Lam.12216 |
0.609 |
|
| 2013 |
Pagès JM, Kascàkovà S, Maigre L, Allam A, Alimi M, Chevalier J, Galardon E, Réfrégiers M, Artaud I. New Peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging. Acs Medicinal Chemistry Letters. 4: 556-9. PMID 24900708 DOI: 10.1021/Ml400073G |
0.415 |
|
| 2013 |
Handzlik J, Szymańska E, Alibert S, Chevalier J, Otrębska E, Pękala E, Pagès JM, Kieć-Kononowicz K. Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin. Bioorganic & Medicinal Chemistry. 21: 135-45. PMID 23218781 DOI: 10.1016/J.Bmc.2012.10.053 |
0.501 |
|
| 2012 |
Fadli M, Chevalier J, Bolla JM, Mezrioui NE, Hassani L, Pages JM. Thymus maroccanus essential oil, a membranotropic compound active on Gram-negative bacteria and resistant isolates Journal of Applied Microbiology. 113: 1120-1129. PMID 22809088 DOI: 10.1111/J.1365-2672.2012.05401.X |
0.461 |
|
| 2012 |
Kaščáková S, Maigre L, Chevalier J, Réfrégiers M, Pagès JM. Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution. Plos One. 7: e38624. PMID 22719907 DOI: 10.1371/Journal.Pone.0038624 |
0.453 |
|
| 2012 |
Huguet F, Melet A, Alves de Sousa R, Lieutaud A, Chevalier J, Maigre L, Deschamps P, Tomas A, Leulliot N, Pages JM, Artaud I. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes. Chemmedchem. 7: 1020-30. PMID 22489069 DOI: 10.1002/Cmdc.201200076 |
0.318 |
|
| 2012 |
Goemaere E, Melet A, Larue V, Lieutaud A, Alves de Sousa R, Chevalier J, Yimga-Djapa L, Giglione C, Huguet F, Alimi M, Meinnel T, Dardel F, Artaud I, Pagès JM. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity. The Journal of Antimicrobial Chemotherapy. 67: 1392-400. PMID 22378679 DOI: 10.1093/Jac/Dks058 |
0.426 |
|
| 2012 |
Fadli M, Saad A, Sayadi S, Chevalier J, Mezrioui NE, Pagès JM, Hassani L. Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 19: 464-71. PMID 22257599 DOI: 10.1016/J.Phymed.2011.12.003 |
0.381 |
|
| 2011 |
Handzlik J, Szymańska E, Chevalier J, Otrębska E, Kieć-Kononowicz K, Pagès JM, Alibert S. Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria. European Journal of Medicinal Chemistry. 46: 5807-16. PMID 22000919 DOI: 10.1016/J.Ejmech.2011.09.032 |
0.444 |
|
| 2011 |
Fadli M, Chevalier J, Saad A, Mezrioui NE, Hassani L, Pages JM. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria. International Journal of Antimicrobial Agents. 38: 325-30. PMID 21752605 DOI: 10.1016/J.Ijantimicag.2011.05.005 |
0.506 |
|
| 2011 |
Bolla JM, Alibert-Franco S, Handzlik J, Chevalier J, Mahamoud A, Boyer G, Kieć-Kononowicz K, Pags JM. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria Febs Letters. 585: 1682-1690. PMID 21549704 DOI: 10.1016/J.Febslet.2011.04.054 |
0.545 |
|
| 2011 |
Biot FV, Valade E, Garnotel E, Chevalier J, Villard C, Thibault FM, Vidal DR, Pagès JM. Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. Plos One. 6: e16892. PMID 21347382 DOI: 10.1371/Journal.Pone.0016892 |
0.524 |
|
| 2011 |
Kuete V, Alibert-Franco S, Eyong KO, Ngameni B, Folefoc GN, Nguemeving JR, Tangmouo JG, Fotso GW, Komguem J, Ouahouo BMW, Bolla JM, Chevalier J, Ngadjui BT, Nkengfack AE, Pags JM. Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype International Journal of Antimicrobial Agents. 37: 156-161. PMID 21163632 DOI: 10.1016/J.Ijantimicag.2010.10.020 |
0.507 |
|
| 2011 |
Mahamoud A, Chevalier J, Baitiche M, Adam E, Pagès JM. An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates. Microbiology (Reading, England). 157: 566-71. PMID 21071494 DOI: 10.1099/Mic.0.045716-0 |
0.55 |
|
| 2010 |
Martins A, Spengler G, Martins M, Rodrigues L, Viveiros M, Davin-Regli A, Chevalier J, Couto I, Pagès JM, Amaral L. Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes. International Journal of Antimicrobial Agents. 36: 313-8. PMID 20688487 DOI: 10.1016/J.Ijantimicag.2010.06.036 |
0.526 |
|
| 2010 |
Bialek S, Lavigne JP, Chevalier J, Marcon E, Leflon-Guibout V, Davin A, Moreau R, Pagès JM, Nicolas-Chanoine MH. Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrobial Agents and Chemotherapy. 54: 4373-8. PMID 20679507 DOI: 10.1128/Aac.01607-09 |
0.561 |
|
| 2010 |
Pagès JM, Alibert-Franco S, Mahamoud A, Bolla JM, Davin-Regli A, Chevalier J, Garnotel E. Efflux pumps of gram-negative bacteria, a new target for new molecules Current Topics in Medicinal Chemistry. 10: 1848-1857. PMID 20615189 DOI: 10.2174/156802610793176620 |
0.54 |
|
| 2010 |
Chevalier J, Mahamoud A, Baitiche M, Adam E, Viveiros M, Smarandache A, Militaru A, Pascu ML, Amaral L, Pagès JM. Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains. International Journal of Antimicrobial Agents. 36: 164-8. PMID 20494558 DOI: 10.1016/J.Ijantimicag.2010.03.027 |
0.513 |
|
| 2010 |
Lavigne JP, Brunel JM, Chevalier J, Pagès JM. Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria. The Journal of Antimicrobial Chemotherapy. 65: 799-801. PMID 20147322 DOI: 10.1093/Jac/Dkq031 |
0.618 |
|
| 2009 |
Mamelli L, Petit S, Chevalier J, Giglione C, Lieutaud A, Meinnel T, Artaud I, Pagès JM. New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors. Plos One. 4: e6443. PMID 19649280 DOI: 10.1371/Journal.Pone.0006443 |
0.462 |
|
| 2009 |
Tran QT, Dupont M, Lavigne JP, Chevalier J, Pagès JM, Sotto A, Davin-Regli A. Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy. 53: 1652-6. PMID 19164140 DOI: 10.1128/Aac.00822-08 |
0.694 |
|
| 2008 |
Chevalier J, Mulfinger C, Garnotel E, Nicolas P, Davin-Régli A, Pagès JM. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. Plos One. 3: e3203. PMID 18787654 DOI: 10.1371/Journal.Pone.0003203 |
0.585 |
|
| 2008 |
Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pagès JM. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens Current Drug Targets. 9: 750-759. PMID 18781921 DOI: 10.2174/138945008785747824 |
0.576 |
|
| 2007 |
Dupont M, James CE, Chevalier J, Pagès JM. An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrobial Agents and Chemotherapy. 51: 3190-8. PMID 17606680 DOI: 10.1128/Aac.01481-06 |
0.688 |
|
| 2007 |
Mahamoud A, Chevalier J, Alibert-Franco S, Kern WV, Pagès JM. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. The Journal of Antimicrobial Chemotherapy. 59: 1223-9. PMID 17229832 DOI: 10.1093/Jac/Dkl493 |
0.536 |
|
| 2006 |
Mahamoud A, Chevalier J, Davin-Regli A, Barbe J, Pagès JM. Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. Current Drug Targets. 7: 843-7. PMID 16842215 DOI: 10.2174/138945006777709557 |
0.551 |
|
| 2006 |
Ghisalberti D, Mahamoud A, Chevalier J, Baitiche M, Martino M, Pagès JM, Barbe J. Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. International Journal of Antimicrobial Agents. 27: 565-9. PMID 16707249 DOI: 10.1016/J.Ijantimicag.2006.03.010 |
0.567 |
|
| 2006 |
Davin-Regli A, Chollet R, Bredin J, Chevalier J, Lepine F, Pagès JM. Enterobacter gergoviae and the prevalence of efflux in parabens resistance. The Journal of Antimicrobial Chemotherapy. 57: 757-60. PMID 16473920 DOI: 10.1093/Jac/Dkl023 |
0.496 |
|
| 2005 |
Braibant M, Chevalier J, Chaslus-Dancla E, Pagès JM, Cloeckaert A. Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily. Antimicrobial Agents and Chemotherapy. 49: 2965-71. PMID 15980376 DOI: 10.1128/Aac.49.7.2965-2971.2005 |
0.381 |
|
| 2005 |
Ghisalberti D, Masi M, Pagès JM, Chevalier J. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochemical and Biophysical Research Communications. 328: 1113-8. PMID 15707992 DOI: 10.1016/J.Bbrc.2005.01.069 |
0.582 |
|
| 2004 |
Chollet R, Chevalier J, Bryskier A, Pagès JM. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrobial Agents and Chemotherapy. 48: 3621-4. PMID 15328143 DOI: 10.1128/Aac.48.9.3621-3624.2004 |
0.562 |
|
| 2004 |
Dupont M, Dé E, Chollet R, Chevalier J, Pagès JM. Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. Febs Letters. 569: 27-30. PMID 15225603 DOI: 10.1016/J.Febslet.2004.05.047 |
0.685 |
|
| 2004 |
Chollet R, Chevalier J, Bollet C, Pages JM, Davin-Regli A. RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrobial Agents and Chemotherapy. 48: 2518-23. PMID 15215103 DOI: 10.1128/Aac.48.7.2518-2523.2004 |
0.567 |
|
| 2004 |
Hasdemir UO, Chevalier J, Nordmann P, Pagès JM. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. Journal of Clinical Microbiology. 42: 2701-6. PMID 15184455 DOI: 10.1128/Jcm.42.6.2701-2706.2004 |
0.585 |
|
| 2004 |
Chevalier J, Bredin J, Mahamoud A, Malléa M, Barbe J, Pagès JM. Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy. 48: 1043-6. PMID 14982806 DOI: 10.1128/Aac.48.3.1043-1046.2004 |
0.583 |
|
| 2003 |
Gallo S, Chevalier J, Mahamoud A, Eyraud A, Pagès JM, Barbe J. 4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain. International Journal of Antimicrobial Agents. 22: 270-3. PMID 13678833 DOI: 10.1016/S0924-8579(03)00215-2 |
0.548 |
|
| 2003 |
Malléa M, Mahamoud A, Chevalier J, Alibert-Franco S, Brouant P, Barbe J, Pagès JM. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. The Biochemical Journal. 376: 801-5. PMID 12959639 DOI: 10.1042/Bj20030963 |
0.564 |
|
| 2003 |
Gayet S, Chollet R, Molle G, Pagès JM, Chevalier J. Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrobial Agents and Chemotherapy. 47: 1555-9. PMID 12709321 DOI: 10.1128/Aac.47.5.1555-1559.2003 |
0.528 |
|
| 2003 |
Bornet C, Chollet R, Malléa M, Chevalier J, Davin-Regli A, Pagès JM, Bollet C. Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochemical and Biophysical Research Communications. 301: 985-90. PMID 12589810 DOI: 10.1016/S0006-291X(03)00074-3 |
0.592 |
|
| 2002 |
Malléa M, Chevalier J, Eyraud A, Pagès JM. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochemical and Biophysical Research Communications. 293: 1370-3. PMID 12054665 DOI: 10.1016/S0006-291X(02)00404-7 |
0.599 |
|
| 2002 |
Chollet R, Bollet C, Chevalier J, Malléa M, Pagès JM, Davin-Regli A. mar Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrobial Agents and Chemotherapy. 46: 1093-7. PMID 11897595 DOI: 10.1128/Aac.46.4.1093-1097.2002 |
0.566 |
|
| 2001 |
Chevalier J, Atifi S, Eyraud A, Mahamoud A, Barbe J, Pages J. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. Journal of Medicinal Chemistry. 44: 4023-4026. PMID 11689091 DOI: 10.1021/Jm010911Z |
0.567 |
|
| 2001 |
Aubert D, Poirel L, Chevalier J, Leotard S, Pages J, Nordmann P. Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. 45: 1615-1620. PMID 11353602 DOI: 10.1128/Aac.45.6.1615-1620.2001 |
0.514 |
|
| 2000 |
CHEVALIER J, MALLÉA M, PAGÈS J. Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae Biochemical Journal. 348: 223. DOI: 10.1042/Bj3480223 |
0.45 |
|
| 2000 |
CHEVALIER J, MALLÉA M, PAGÈS J. Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae Biochemical Journal. 348: 223-227. DOI: 10.1042/BJ3480223 |
0.328 |
|
| 2000 |
Chevalier J, Pagès J, Eyraud A, Malléa M. Membrane Permeability Modifications Are Involved in Antibiotic Resistance in Klebsiella pneumoniae Biochemical and Biophysical Research Communications. 274: 496-499. DOI: 10.1006/Bbrc.2000.3159 |
0.576 |
|
| 1999 |
Chevalier J, Pagès J, Malléa M. In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes. Biochemical and Biophysical Research Communications. 266: 248-251. PMID 10581197 DOI: 10.1006/Bbrc.1999.1795 |
0.581 |
|
| 1998 |
Mallea M, Chevalier J, Bornet C, Eyraud A, Davin-Regli A, Bollet C, Pages JM. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology (Reading, England). 144: 3003-3009. PMID 9846735 DOI: 10.1099/00221287-144-11-3003 |
0.622 |
|
| 1998 |
Kolli ME, Coulibaly A, Chevalier J, Barbe J, Crémieux A. Antibacterial activity of 5-aminoorotic acid derivatives. Current Microbiology. 36: 245-247. PMID 9504994 DOI: 10.1007/S002849900303 |
0.371 |
|
| 1998 |
Mallea M, Chevalier J, Bornet C, Eyraud A, Davin-Regli A, Bollet C, Pages J. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes Microbiology. 144: 3003-3009. DOI: 10.1099/00221287-144-11-3003 |
0.326 |
|
| 1996 |
Kolli ME, Mahamoud A, Coulibaly A, Chevalier J, Cremieux A, Barbe J. Synthesis Of New 5-Aminoorotic Acid Derivatives As Antimicrobial Agents Heterocyclic Communications. 2: 531-538. DOI: 10.1515/Hc.1996.2.6.531 |
0.3 |
|
| 1990 |
Ngadi L, Galy A, Galy J, Barbe J, Crémieux A, Chevalier J, Sharples D. Some new 1-nitro acridine derivatives as antimicrobial agents European Journal of Medicinal Chemistry. 25: 67-70. DOI: 10.1016/0223-5234(90)90166-Z |
0.372 |
|
| Show low-probability matches. |